Literature DB >> 15708852

Requirement of Tyr-992 and Tyr-1173 in phosphorylation of the epidermal growth factor receptor by ionizing radiation and modulation by SHP2.

Lisa-Marie Sturla1, George Amorino, Michael S Alexander, Ross B Mikkelsen, Kristoffer Valerie, Rupert K Schmidt-Ullrichr.   

Abstract

The epidermal growth factor receptor (EGFR) is activated by ionizing radiation (IR) in many human carcinomas, mediating a cytoprotective response and subsequent radioresistance. The underlying molecular mechanisms remain to be understood, and we propose here a specific role for the Tyr-992 residue of EGFR and examine its regulation by the phosphatase, SHP2. The -fold increase in phosphorylation of Tyr-992 in response to IR is twice that seen with ligand (EGF) binding. Mutation of Tyr-992 blocked completely IR-induced EGFR phosphorylation and reduced activation of the downstream signaling molecule, phospholipase Cgamma. IR has previously been demonstrated to inhibit activity of protein-tyrosine phosphatases. Following protein-tyrosine phosphatase inhibition by sodium vanadate both EGFR expressing Chinese hamster ovary (CHO) and A431 exhibited up to an 8-fold increase in the basal level of Tyr-992 phosphorylation, significantly higher than that seen with Tyr-1173, Tyr-1068, and total EGFR Tyr. CHO cells expressing a SHP2 mutant also demonstrated up to an 8-fold increase in the basal level of Tyr-992 phosphorylation. In this study we show the unique association of SHP2 with EGFR in response to IR, with up to a 2.5-fold increase in the direct association of endogenous SHP2 with EGFR-wt in response to 2 gray of IR in both CHO and A431 cells. Mutation of Tyr-992 abolished this response. In conclusion we have identified several differentially activated Tyr residues, one of which is not only more sensitive to activation by IR, translating into differential activation of downstream signaling, but uniquely modulated by the phosphatase SHP2.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15708852     DOI: 10.1074/jbc.M413287200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Human epidermal growth factor receptor 3 (HER3) blockade with U3-1287/AMG888 enhances the efficacy of radiation therapy in lung and head and neck carcinoma.

Authors:  Chunrong Li; Toni M Brand; Mari Iida; Shyhmin Huang; Eric A Armstrong; Albert van der Kogel; Deric L Wheeler
Journal:  Discov Med       Date:  2013-09       Impact factor: 2.970

2.  The Role of Nitric Oxide Synthase Uncoupling in Tumor Progression.

Authors:  Christopher S Rabender; Asim Alam; Gobalakrishnan Sundaresan; Robert J Cardnell; Vasily A Yakovlev; Nitai D Mukhopadhyay; Paul Graves; Jamal Zweit; Ross B Mikkelsen
Journal:  Mol Cancer Res       Date:  2015-02-27       Impact factor: 5.852

3.  Distinct activation of epidermal growth factor receptor by UTP contributes to epithelial cell wound repair.

Authors:  Ilene Boucher; Amanuel Kehasse; Meredith Marcincin; Celeste Rich; Nader Rahimi; Vickery Trinkaus-Randall
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

4.  SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells.

Authors:  Hiroyuki Ozawa; Ruchira S Ranaweera; Evgeny Izumchenko; Eugene Makarev; Alex Zhavoronkov; Elana J Fertig; Jason D Howard; Ana Markovic; Atul Bedi; Rajani Ravi; Jimena Perez; Quynh-Thu Le; Christina S Kong; Richard C Jordan; Hao Wang; Hyunseok Kang; Harry Quon; David Sidransky; Christine H Chung
Journal:  Clin Cancer Res       Date:  2017-05-18       Impact factor: 12.531

5.  Carcinoma cells induce lumen filling and EMT in epithelial cells through soluble E-cadherin-mediated activation of EGFR.

Authors:  Pratima U Patil; Julia D'Ambrosio; Landon J Inge; Robert W Mason; Ayyappan K Rajasekaran
Journal:  J Cell Sci       Date:  2015-10-19       Impact factor: 5.285

6.  Neutral Loss Is a Very Common Occurrence in Phosphotyrosine-Containing Peptides Labeled with Isobaric Tags.

Authors:  Robert A Everley; Edward L Huttlin; Alison R Erickson; Sean A Beausoleil; Steven P Gygi
Journal:  J Proteome Res       Date:  2016-12-30       Impact factor: 4.466

7.  Heparanase augments epidermal growth factor receptor phosphorylation: correlation with head and neck tumor progression.

Authors:  Victoria Cohen-Kaplan; Ilana Doweck; Inna Naroditsky; Israel Vlodavsky; Neta Ilan
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

Review 8.  Nexus of signaling and endocytosis in oncogenesis driven by non-small cell lung cancer-associated epidermal growth factor receptor mutants.

Authors:  Byung Min Chung; Eric Tom; Neha Zutshi; Timothy Alan Bielecki; Vimla Band; Hamid Band
Journal:  World J Clin Oncol       Date:  2014-12-10

Review 9.  Improving gemcitabine-mediated radiosensitization using molecularly targeted therapy: a review.

Authors:  Meredith A Morgan; Leslie A Parsels; Jonathan Maybaum; Theodore S Lawrence
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

10.  Injury and nucleotides induce phosphorylation of epidermal growth factor receptor: MMP and HB-EGF dependent pathway.

Authors:  Ilene Boucher; LingLing Yang; Courtney Mayo; Veronica Klepeis; Vickery Trinkaus-Randall
Journal:  Exp Eye Res       Date:  2007-03-31       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.